9
H index
8
i10 index
432
Citations
Scuola Superiore Sant'Anna | 9 H index 8 i10 index 432 Citations RESEARCH PRODUCTION: 18 Articles 37 Papers RESEARCH ACTIVITY: 22 years (2001 - 2023). See details. MORE DETAILS IN: ABOUT THIS REPORT: Permalink: http://citec.repec.org/pma1141 |
Works with: Authors registered in RePEc who have co-authored more than one work in the last five years with Laura Magazzini. | Is cited by: | Cites to: |
Journals with more than one article published | # docs |
---|---|
Stata Journal | 3 |
The European Journal of Health Economics | 2 |
Econometric Reviews | 2 |
Year | Title of citing document |
---|---|
2024 | Valuing Pharmaceutical Drug Innovations: An Event Study Approach. (2022). Khmelnitskaya, Ekaterina ; Farmer, Leland E ; Ciliberto, Federico ; Aryal, Gaurab. In: Papers. RePEc:arx:papers:2212.07384. Full description at Econpapers || Download paper |
2023 | International R&D and MNCs innovation performance: An integrated approach. (2023). Belderbos, Rene ; Leten, Bart ; Suzuki, Shinya. In: Journal of International Management. RePEc:eee:intman:v:29:y:2023:i:6:s1075425323000807. Full description at Econpapers || Download paper |
2023 | The short- and long-run effects of medical malpractice lawsuits on medical spending and hospital operations in China. (2023). Yi, Junjian ; Liu, Gordon ; Zhao, Shaoyang ; Yuan, YE. In: Journal of Comparative Economics. RePEc:eee:jcecon:v:51:y:2023:i:4:p:1142-1161. Full description at Econpapers || Download paper |
2023 | Do patents really foster innovation in the pharmaceutical sector? Results from an evolutionary, agent-based model. (2023). Roventini, Andrea ; Dosi, Giovanni ; Russo, Emanuele ; Palagi, Elisa. In: Journal of Economic Behavior & Organization. RePEc:eee:jeborg:v:212:y:2023:i:c:p:564-589. Full description at Econpapers || Download paper |
2023 | Private and social functions of patents: Innovation, markets, and new firms. (2023). Gambardella, Alfonso. In: Research Policy. RePEc:eee:respol:v:52:y:2023:i:7:s0048733323000902. Full description at Econpapers || Download paper |
2023 | The role of patient organisations in research and development: Evidence from rare diseases. (2023). Miraldo, Marisa ; Gentilini, Arianna. In: Social Science & Medicine. RePEc:eee:socmed:v:338:y:2023:i:c:s0277953623006895. Full description at Econpapers || Download paper |
2023 | Overcoming the challenge of exploration: How decompartmentalization of internal communication enhances the effect of exploration on employee inventive performance. (2023). Turban, Daniel B ; Clark, Brent B ; Jiang, Lin. In: Technovation. RePEc:eee:techno:v:119:y:2023:i:c:s0166497222001584. Full description at Econpapers || Download paper |
2024 | The role of the quality infrastructure within socio-technical transformations: A European perspective. (2024). Blind, Knut. In: Technological Forecasting and Social Change. RePEc:eee:tefoso:v:199:y:2024:i:c:s0040162523007047. Full description at Econpapers || Download paper |
2023 | Determinants of Commercialization Modes of Science: Evidence from panel data of university technology transfer in Japan. (2023). Nobuya, Fukugawa. In: Discussion papers. RePEc:eti:dpaper:23053. Full description at Econpapers || Download paper |
2023 | The Relationship between Urbanization and Consumption Upgrading of Rural Residents under the Sustainable Development: An Empirical Study Based on Mediation Effect and Threshold Effect. (2023). Gao, Kuo ; Shao, Xinxin ; Le, Xiaobing. In: Sustainability. RePEc:gam:jsusta:v:15:y:2023:i:10:p:8426-:d:1152995. Full description at Econpapers || Download paper |
2024 | The impact of G7 trade policies on economic development in Africa. (2024). Wolf, Moritz. In: Jena Economics Research Papers. RePEc:jrp:jrpwrp:2024-005. Full description at Econpapers || Download paper |
2023 | Navigating the open innovation paradox: an integrative framework for adopting open innovation in pharmaceutical R&D in developing countries. (2023). Dorfler, Viktor ; Bhatnagar, Bhawani ; MacBryde, Jillian. In: The Journal of Technology Transfer. RePEc:kap:jtecht:v:48:y:2023:i:6:d:10.1007_s10961-022-09958-6. Full description at Econpapers || Download paper |
2024 | R&D collaboration, social coordination, and standardization: evidence from the Chinese automotive industry. (2024). Pennings, Enrico ; Zeng, Deming ; Karreman, Bas ; Feng, KE. In: The Journal of Technology Transfer. RePEc:kap:jtecht:v:49:y:2024:i:1:d:10.1007_s10961-022-09972-8. Full description at Econpapers || Download paper |
2024 | Many are called, few are chosen: the role of science in drug development decisions. (2024). Belderbos, Rene ; Kelchtermans, Stijn ; Leten, Bart ; Colen, Linde. In: The Journal of Technology Transfer. RePEc:kap:jtecht:v:49:y:2024:i:2:d:10.1007_s10961-022-09982-6. Full description at Econpapers || Download paper |
2023 | The timing dilemma: understanding the determinants of innovative startupsâ patent collateralization for loans. (2023). Wu, Bingde ; Hu, Die ; Zhang, Hao ; Yang, Xue. In: Small Business Economics. RePEc:kap:sbusec:v:60:y:2023:i:1:d:10.1007_s11187-022-00645-2. Full description at Econpapers || Download paper |
2024 | Can we map innovation capabilities?. (2024). Yildirim, Muhammed A ; Raffo, Julio ; Rodriguez, Eduardo Hernandez ; Hartog, Matte ; Matha, Shreyas Gadgin ; Chacua, Christian ; Moscatelli, Federico. In: WIPO Economic Research Working Papers. RePEc:wip:wpaper:81. Full description at Econpapers || Download paper |
Year | Title | Type | Cited |
---|---|---|---|
2019 | Does regulation drive international research cooperation? Evidence from the pharmaceutical sector In: The World Economy. [Full Text][Citation analysis] | article | 0 |
In: . [Full Text][Citation analysis] | paper | 0 | |
In: . [Full Text][Citation analysis] | paper | 1 | |
2006 | Everything You Always Wanted to Know about Inventors (But Never Asked): Evidence from the PatVal-EU Survey In: CEPR Discussion Papers. [Full Text][Citation analysis] | paper | 33 |
2005 | Everything you Always Wanted to Know about Inventors (but Never Asked): Evidence from the PatVal-EU Survey.(2005) In: LEM Papers Series. [Full Text][Citation analysis] This paper has nother version. Agregated cites: 33 | paper | |
2009 | A Breath of Fresh Air? Firm Type, Scale, Scope and Selection Effects in Drug Development. In: KITeS Working Papers. [Citation analysis] | paper | 42 |
2009 | A Breath of Fresh Air? Firm Type, Scale, Scope, and Selection Effects in Drug Development.(2009) In: Management Science. [Full Text][Citation analysis] This paper has nother version. Agregated cites: 42 | article | |
2007 | A Breath of Fresh Air? Firm types, scale, scope and selection effects in drug development.(2007) In: MPRA Paper. [Full Text][Citation analysis] This paper has nother version. Agregated cites: 42 | paper | |
2013 | Resale Price Maintenance: An Empirical Analysis of UK Firms Compliance In: Economic Journal. [Full Text][Citation analysis] | article | 1 |
2020 | Exploiting information from singletons in panel data analysis: A GMM approach In: Economics Letters. [Full Text][Citation analysis] | article | 2 |
2019 | Exploiting Information from Singletons in Panel Data Analysis: A GMM Approach.(2019) In: IZA Discussion Papers. [Full Text][Citation analysis] This paper has nother version. Agregated cites: 2 | paper | |
2021 | R&D and market size: Who benefits from orphan drug legislation? In: Journal of Health Economics. [Full Text][Citation analysis] | article | 3 |
2007 | Inventors and invention processes in Europe: Results from the PatVal-EU survey In: Research Policy. [Full Text][Citation analysis] | article | 180 |
2003 | Il Decreto DL 15/04/2002, n. 63 sul Contenimento della Spesa Farmaceutica - Impatto sullIndustria e Distorsioni nel Funzionamento del Mercato In: Working Papers CERM. [Full Text][Citation analysis] | paper | 0 |
2005 | Generici vs. Branded: confronto internazionale su prodotti off-patent rimborsati dal SSN In: Working Papers CERM. [Full Text][Citation analysis] | paper | 0 |
2014 | Dinamiche di mercato e intensitĂÂ della concorrenza di prezzo nel segmento dei farmaci off patent. La posizione dellItalia nel contesto europeo. In: Working Papers CERM. [Full Text][Citation analysis] | paper | 0 |
2006 | La spesa farmaceutica pubblica - Analisi degli ultimi anni e indicazioni per una nuova politica economica In: Working Papers CERM. [Full Text][Citation analysis] | paper | 0 |
2007 | La spesa farmaceutica territoriale convenzionata: il modello FarmaRegio per lanalisi della variabilitĂÂ regionale In: Working Papers CERM. [Full Text][Citation analysis] | paper | 4 |
2009 | Nuove politiche per linnovazione nel settore delle scienze della vita In: Working Papers CERM. [Full Text][Citation analysis] | paper | 0 |
2007 | Il prezzo di riferimento nel quadro regolatorio del mercato farmaceutico In: Working Papers CERM. [Full Text][Citation analysis] | paper | 0 |
2005 | Medical Devices: Competitiveness and Impact on Public Health Expenditure In: Working Papers CERM. [Full Text][Citation analysis] | paper | 18 |
2005 | Medical Devices Competitiveness and Impact on Public Health Expenditure.(2005) In: MPRA Paper. [Full Text][Citation analysis] This paper has nother version. Agregated cites: 18 | paper | |
2012 | The Value of Failures in Pharmaceutical R&D In: Working Papers. [Full Text][Citation analysis] | paper | 4 |
2013 | R&D, Within and Between Patent Competition in the Pharmaceutical Industry In: Working Papers. [Full Text][Citation analysis] | paper | 0 |
2022 | The Identification of Time-Invariant Variables in Panel Data Model: Exploring the Role of Science in Firmsâ Productivity In: IZA Discussion Papers. [Full Text][Citation analysis] | paper | 0 |
2004 | Dynamic Competition in Pharmaceuticals: Patent Expiry, Generic Penetration, and Industry Structure In: MPRA Paper. [Full Text][Citation analysis] | paper | 19 |
2008 | The Sustainability of European Health Care Systems: Beyond Income and Ageing In: MPRA Paper. [Full Text][Citation analysis] | paper | 22 |
2012 | The sustainability of European health care systems: beyond income and aging.(2012) In: The European Journal of Health Economics. [Full Text][Citation analysis] This paper has nother version. Agregated cites: 22 | article | |
2008 | The Sustainability of European Health Care Systems: Beyond Income and Ageing.(2008) In: Working Papers. [Full Text][Citation analysis] This paper has nother version. Agregated cites: 22 | paper | |
2001 | Simulation-based estimation of Tobit model with random effects In: MPRA Paper. [Full Text][Citation analysis] | paper | 5 |
2002 | The intensity of competition after patent expiry in pharmaceuticals. A cross-country analysis In: Revue d'Ăconomie Industrielle. [Full Text][Citation analysis] | article | 9 |
2012 | Autocorrelation and masked heterogeneity in panel data models estimated by maximum likelihood In: Empirical Economics. [Full Text][Citation analysis] | article | 4 |
2009 | Autocorrelation and masked heterogeneity in panel data models estimated by maximum likelihood.(2009) In: Working Papers. [Full Text][Citation analysis] This paper has nother version. Agregated cites: 4 | paper | |
2004 | Dynamic competition in pharmaceuticals In: The European Journal of Health Economics. [Full Text][Citation analysis] | article | 23 |
2016 | Learning from successes and failures in pharmaceutical R&D In: Journal of Evolutionary Economics. [Full Text][Citation analysis] | article | 5 |
2023 | Assessing individual skill influence on housework time of Italian women: an endogenous-switching approach In: Statistical Methods & Applications. [Full Text][Citation analysis] | article | 0 |
2009 | Patent disclosure and R&D competition in pharmaceuticals In: Economics of Innovation and New Technology. [Full Text][Citation analysis] | article | 6 |
2009 | Patent Disclosure and R&D Competition in Pharmaceuticals..(2009) In: DISA Working Papers. [Full Text][Citation analysis] This paper has nother version. Agregated cites: 6 | paper | |
2009 | Patent Disclosure and R&D Competition in Pharmaceuticals..(2009) In: ROCK Working Papers. [Full Text][Citation analysis] This paper has nother version. Agregated cites: 6 | paper | |
2019 | Testing initial conditions in dynamic panel data models In: Econometric Reviews. [Full Text][Citation analysis] | article | 2 |
2020 | Testing initial conditions in dynamic panel data models.(2020) In: Econometric Reviews. [Full Text][Citation analysis] This paper has nother version. Agregated cites: 2 | article | |
2020 | Using information from singletons in fixed-effects estimation: xtfesing In: Stata Journal. [Full Text][Citation analysis] | article | 0 |
2021 | Maximum likelihood estimation of an across-regime correlation parameter In: Stata Journal. [Full Text][Citation analysis] | article | 0 |
2023 | A Lagrange multiplier test for the mean stationarity assumption in dynamic panel-data models In: Stata Journal. [Full Text][Citation analysis] | article | 1 |
2011 | International Cooperation in Pharmaceutical Research In: Working Paper series, University of East Anglia, Centre for Competition Policy (CCP). [Full Text][Citation analysis] | paper | 0 |
2009 | International Cooperation in Pharmaceutical Research.(2009) In: Working Papers. [Full Text][Citation analysis] This paper has nother version. Agregated cites: 0 | paper | |
2011 | Moment Conditions and Neglected Endogeneity in Panel Data Models In: Working Papers. [Full Text][Citation analysis] | paper | 0 |
2018 | The Joint Estimate of Singleton and Longitudinal Observations: a GMM Approach for Improved Efficiency In: Working Papers. [Full Text][Citation analysis] | paper | 0 |
2010 | The productivity crisis in pharmaceutical R&D In: Working Papers. [Full Text][Citation analysis] | paper | 41 |
2012 | Identification of linear panel data models when instruments are not available In: Working Papers. [Full Text][Citation analysis] | paper | 0 |
2019 | R&D and market size: who benefits from orphan drug regulation? In: Working Papers. [Full Text][Citation analysis] | paper | 1 |
2014 | Improving GMM efficiency in dynamic models for panel data with mean stationarity In: Working Papers. [Full Text][Citation analysis] | paper | 1 |
2013 | A powerful test of mean stationarity in dynamic models for panel data: Monte Carlo evidence In: Working Papers. [Full Text][Citation analysis] | paper | 2 |
2010 | Negative variance estimates in panel data models In: Working Papers. [Full Text][Citation analysis] | paper | 3 |
2008 | Patent Value and R&D Competition In: Working Papers. [Full Text][Citation analysis] | paper | 0 |
CitEc is a RePEc service, providing citation data for Economics since 2001. Last updated November, 3 2024. Contact: CitEc Team